The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? (Q46382169)

21 December 2017

title

The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? (English)

1 reference

21 December 2017

left ventricular hypertrophy

main subject

patient

0 references

1 reference

inferred from title

coronary artery disease

1 reference

5

Eric D Peterson

1 reference

21 December 2017

Mark A East

1

1 reference

21 December 2017

James G Jollis

series ordinal

2

1 reference

21 December 2017

Charlotte L Nelson

series ordinal

3

1 reference

21 December 2017

David Marks

series ordinal

4

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

21 December 2017

Journal of the American College of Cardiology

published in

1 reference

21 December 2017

volume

41

1 reference

21 December 2017

issue

6

1 reference

21 December 2017

page(s)

949-954

1 reference

21 December 2017

Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Left ventricular hypertrophy has a greater impact on survival in women than in men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Risk stratification after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Measurement of left ventricular wall thickness and mass by echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Standardization of M-mode echocardiographic left ventricular anatomic measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Mortality ascertainment in the veteran population: alternatives to the National Death Index

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Role of blood pressure in the development of congestive heart failure. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Angiotensin II and sympathetic activity in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Angiotensin II. Adrenergic sympathetic constrictor action in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2903006-1

7 January 2021

10.1016/S0735-1097(02)03006-1

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

12651039

1 reference

21 December 2017